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abstract
Organophosphate poisoning in the context of self-harm is a common medical emergency in Asia. Prolonged 
muscle weakness is an important but poorly understood cause of morbidity and mortality of the poisoning. This 
study examined mitochondrial function and its modulation by nitric oxide in muscle weakness of rats exposed 
to an acute, oral (0.8LD50) dose of monocrotophos. Muscle mitochondrial ATP synthase activity was inhibited in 
the rat in acute exposure to monocrotophos while respiration per se was not affected. This was accompanied by 
decreased mitochondrial uptake of calcium and increased levels of nitric oxide. Reactive cysteine groups of ATP 
synthase subunits were reduced in number ,which may contribute to decreased enzyme activity. The decrease 
in ATP synthase activity and reactive cysteine groups of ATP synthase subunits was prevented by treatment of 
animals with the nitric oxide synthase inhibitor, L-NG Nitroarginine methyl ester, at 12 mg/kg body weight for 
9 days in drinking water, prior to monocrotophos exposure. This indicated a role for nitric oxide in the process. 
The alterations in mitochondrial calcium uptake may influence cytosolic calcium levels and contribute to muscle 
weakness of acute organophosphate exposure.
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Introduction
Organophosphorous  pesticide  poisoning  is  a  common 
method  of  intentional  self-harm  in  agricultural  com-
munities  across  Asia  (Eddleston  and  Phillips  2004). 
Organophosphates  inhibit  acetylcholinsterase  (AChE), 
leading to an accumulation of acetylcholine at cholinergic 
synapses in the central nervous system and at neuromus-
cular junctions, and that results in overstimulation of these 
systems. In severe acute organophosphate poisoning (OPP) 
this can result in an autonomic cholinergic storm and lead 
to prolonged neuromuscular weakness and paralysis. The 
pathophysiology underlying muscle weakness that occurs 
in acute OPP is not completely clear, and thus there is no 
specific treatment for it. Consequently it is a major cause 
of  morbidity  and  mortality  of  hospitalized  OPP  patients 
(Samuel et al. 1995).
Severe,  persistent  inhibition  of  AChE  is  the  primary 
event responsible for muscle weakness that occurs in OPP. 240    S. Venkatesh et al.
However it is unlikely to be the only factor, as cholinergic 
symptoms are often absent in prolonged muscle weakness 
and muscle power recovers despite persistent cholineste-
rase inhibition.
Functional  mitochondria  are  essential  in  maintaining 
the integrity of the high energy requiring skeletal muscle. 
Muscle  weakness  often  occurs  subsequent  to  dysregula-
tion of mitochondrial respiration and energy production, 
and  consequent  perturbation  of  intracellular  Ca2+  levels 
(DiMauro and Gurgel-Giannetti 2005; Sarnat and Marin-
Garcia 2005). It is possible that, during acute OPP, inhibition 
of mitochondrial function in the muscle also contributes to 
muscle weakness. This was studied in paralyzed skeletal 
muscle, in the early phase of poisoning, in rats subjected 
to severe acute monocrotophos exposure, an organophos-
phorus pesticide commonly used in India for intentional 
self-harm.
Acetylcholine,  acting  through  its  receptor,  is  known 
to increase cytosolic Ca2+ released from the endoplasmic 
reticulum, resulting in activation of calmodulin that stimu-
lates nitric oxide synthase (NOS) and production of nitric 
oxide (NO). Increased levels of NO are a natural sequence 
to the inhibition of AChE by organophosphates. This study 
also examined nitric oxide signaling, activated in OPP, in 
modulating  muscle  mitochondrial  function  during  the 
early phase of poisoning, as nitric oxide is known to modify 
mitochondrial  proteins  and  disrupt  mitochondrial  func-
tion, including the ability to control calcium (Dedkova and 
Blatter 2005).
Materials and methods
n-Dodecyl-maltoside, Tricine, aminocaproic acid, Brilliant 
blue G and R, Cytochrome C (from bovine heart), phos-
phoenol pyruvate, pyruvate kinase, lactic acid dehydroge-
nase, oligomycin, sodium succinate dibasic hexahydrate, 
glutamate (disodium salt), rotenone, Nagarse (proteinase 
enzyme  III),  biotin-maleimide,  and  L-NG  Nitroarginine 
methyl ester (L-NAME) were obtained from Sigma Aldrich 
Inc.  (St  Loius,  MO).  Streptavidin  linked  secondary  anti-
bodies and streptavidin peroxidase were from Bangalore 
Genei  Pvt,  Ltd.  (Bangalore,  India).  Mouse  monoclonal 
antibodies  to  ,  ,  and  oligomycin  sensitivity  confer-
ring protein (OSCP) subunits of ATP synthase were from 
Invitrogen (USA). Bovine serum albumin was from National 
Biochemical Corp. (USA). Monocrotophos (36% SL), con-
taining no other compounds, was from Syngenta India Pvt 
Ltd. (India). All other chemicals were of the highest purity 
available.
Animal studies
Wistar rats (female, 150 ± 5 g) were administered monocro-
tophos  by  gavage  at  a  dose  of  0.8  LD50  in  200 l  water 
(Monocrotophos LD50 = 18 mg/kg body weight) (Manhande 
and Chopde 1995). Control rats were administered 200 l 
water by gavage. Animals were evaluated after exposure 
to monocrotophos for cholinergic signs (chewing, tremor, 
salivation,  lacrimation,  and  diarrhea)  and  for  muscle 
power  (Grade  0:  normal  mobility,  Grade  1:  ataxic  gait, 
Grade 2: stretch movements after tail stimulation or Grade 
3:  no  voluntary  movements  after  tail  stimulation)  (De 
Bleecker et al. 1991). Monocrotophos was administered 
between 8 and 9 am on days of study and animals were 
sacrificed 2.5 h later when they were paralyzed (no vol-
untary movements after tail stimulation). Animals were 
euthanized  under  ether  anesthesia.  Blood  (2.0 ml)  was 
collected from each rat on sacrifice and RBC and plasma 
separated and stored at −70°C until assay. For inhibition 
of nitric oxide synthase (NOS), L-NAME (hydrochloride) 
was given to rats in drinking water at a dose of 0.1 mg/ml/
day (12 mg/kg body weight/day) for 9 days (Thomas et al. 
2001), following which they were administered monocro-
tophos as mentioned above. Each parameter was studied 
in a minimum of six rats. The study was approved by the 
Institutional Review Board and Institutional Animal Ethics 
Committee of the Christian Medical College, Vellore.
Skeletal muscle mitochondrial isolation
On sacrifice, upper and lower limb skeletal muscles were 
immediately dissected from the animal and rinsed with 
50 mM  Tris  HCl  pH  7.4  containing  100 mM  KCl/2 mM 
EGTA.  Five  grams  of  muscle  were  finely  minced  and 
incubated for 3 min in eight volumes of buffer containing 
Nagarase (2.1 U/ml), 1 mM ATP, 5 mM MgCl2, 0.5% BSA, 
homogenized in a Dounce homogenizer and centrifuged 
at  490 g  for  10 min  at  4°C  to  obtain  the  post-nuclear 
supernatant. This was filtered through nylon cloth and 
the filtrate spun at 10,300 g for 10 min at 4°C. The mito-
chondrial pellet obtained was washed by re-suspension 
in 50 mM Tris HCl pH 7.4/100 mM KCl (30 ml) and cen-
trifugation  at  10,300 g  for  10  min  at  4°C.  Washing  was 
done twice and the final mitochondrial pellet was sus-
pended in 1.0 ml of buffer. Enrichment of the mitochon-
drial  fraction  was  assessed  by  measuring  the  marker 
enzyme  succinate  dehydrogenase  (Pennington  1961). 
Mitochondria isolated from muscle of non-poisoned rats 
served as controls.
Assay of cholinesterases
Plasma  butyrylcholinesterase  and  RBC  and  brain  acetyl-
cholinesterase were assayed by the method of Ellman et al. 
(1961) using butyrylthiocholine iodide or acetylthiocholine 
iodide, respectively, as substrates. Enzyme units were calcu-
lated from the molar extinction co-efficient of 5-mercapto–2
-nitro benzoic acid of 13.6 × 103.
Protein  was  estimated  by  the  method  of  Lowry  et  al. 
(1951) using bovine serum albumin as standard.
Mitochondrial respiration, swelling, and calcium flux
Oxygen uptake was determined polarographically using a 
Clark type electrode. Mitochondria (300 µg protein) were 
suspended in 2.0 ml 150 mM sucrose, 1 mM KH2 PO4, 5 mM 
MgCl2, 20 mM KCl, 10 mM Tris HCl pH 7.4 containing either 
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allowed to stabilize for 3 min and oxygen uptake measured 
(State  4  respiration).  Oxygen  uptake  stimulated  by  addi-
tion  of  0.3 mM  ADP  was  assessed  as  State  3  respiration. 
The respiratory control ratio was calculated as the ratio of   
State  3/State  4  respiration  (Madesh  et  al.  1999). 
Mitochondrial swelling was assessed by following the drop 
in absorbance at A540 nm as described earlier (Takeyama 
et al. 1993), and calcium flux measurements were carried 
out by   quantifying changes in the absorption spectrum of 
Arsenazo III at 675/685 nm (Scarpa 1979).
Assay of mitochondrial complex IV and V
Complex  IV  activity  was  measured  by  the  oxidation  of 
cytochrome c at 550 nm (Darley-Usmar 1987). Data is rep-
resented as the pseudo first order rate constant (k) divided 
by the protein concentration. Complex V was assayed by an 
ATPase coupled reaction measuring oxidation of NADH at 
340 nm at 30°C in the presence and absence of oligomycin 
(Soper and Pedersen 1979). Units were defined as µmoles 
NADH oxidized/min/mg protein.
2D Blue native gel electrophoresis of mitochondrial 
complexes
Blue Native polyacrylamide gel electrophoresis (BN-PAGE) 
was performed using the method developed by Schagger 
and  von  Jagow  (1991)  and  Schagger  et  al.  (1994),  and 
  modified  by  Brookes  et  al.  (2002).  Mitochondrial  pellets 
(0.5 mg of protein) were resuspended in 80 µl of extraction 
buffer (0.75 M aminocaproic acid, 50 mM BisTris, and 1% 
n-dodecyl-ß-D-maltoside),  incubated  on  ice  for  60  min, 
centrifuged at 14,000 rpm for 5 min, and the supernatants 
containing  the  extracted  mitochondrial  complexes  col-
lected and kept on ice; 2.5 µl of Coomassie Brilliant Blue 
G-250 (5% w/v suspension in 0.5 M aminocaproic acid) was 
added to 75 µg of mitochondrial protein and samples stored 
on ice for no more than 30 min before being subjected to 
non-denaturing  PAGE  (5–12%  gels)  to  separate  the  indi-
vidual respiratory complexes intact. The identity of the ATP 
synthase band in mitochondria subjected to BN-PAGE was 
confirmed by electro-transfer of the gel to PVDF membranes 
and probing the blots with antibodies to the -subunit of 
complex V.
SDS-PAGE, Immunoblotting, and sulfhydryl group 
labeling of ATP synthase
In  further  experiments,  the  band  corresponding  to  ATP 
synthase in BN-PAGE was excised from the gel and sub-
jected  to  2nd  dimension  SDS-PAGE  (10–14%  gels)  with 
-mercaptoethanol to separate individual proteins in the 
complex.  Control  and  monocrotophos  treated  samples 
were run in duplicate so that one gel could be stained with 
Brilliant blue R for protein visualization and the other trans-
ferred to PVDF membranes and probed with antibodies to 
ATP synthase subunits , , and OSCP or analyzed for free 
sulfhydryl  groups.  SDS-PAGE  and  immunoblotting  were 
performed according to standard protocols (Laemmli 1970; 
Towbin et al. 1979).
For labeling of free sulfhydryl groups on subunits of ATP 
synthase, the blots were incubated with biotin-maleimide 
(12 µg/ml) for 12 h at 4°C, blocked with 2% BSA in PBS Tween 
20 (0.02%) for 1 h and incubated with streptavidin-peroxi-
dase (1:5000 diluted) for 45 min. Bands were developed with 
0.024% H2O2/3.2 mM diaminobenzidine for 5 min and quan-
tified using densitometric software developed in-house that 
correlated with Bio-Rad Quantity One Quantitation software 
version 4 (r = 0.8). Under these conditions, modification of 
thiol  groups  is  reflected  in  decreased  labeling  relative  to 
control.
Estimation of nitrate in mitochondria and plasma
Nitrate in mitochondria (100 µg) and plasma (100 µl) was 
first reduced to nitrite with copper-cadmium alloy and then 
assayed by the Griess reaction (Sastry et al. 2002).
Statistical analysis
Parameters under study in monocrotophos treated animals 
were statistically analyzed for differences from controls by 
the Mann Whitney U-test using the statistical software pack-
age SPSS 11.00. A test was considered statistically significant 
at p < 0.05.
Results
Monocrotophos Treatment of Rats
In rats administered monocrotophos (0.8LD50) RBC AChE 
was inhibited 97% and plasma BuChE 91.5% within 2.5 h 
of poisoning. RBC AChE levels in control rats were 8.96 
± 0.456 units/mg protein that decreased to 0.253 ± 0.218 
units/mg  protein  in  monocrotophos  treated  animals 
(mean ± SD, n = 6). The values for plasma BuChE levels 
were 313.23 ± 34.72 units/liter and 26.69 ± 8.98 units/
liter  in  control  and  monocrotophos  treated  animals, 
respectively.
All rats treated with monocrotophos exhibited choliner-
gic symptoms and muscle weakness. Cholinergic symptoms 
began at 12.92 ± 5.58 min and continued until 41 ± 12.21 min 
after  acute  monocrotophos  poisoning.  Muscle  weakness 
developed at 37.5 ± 26.94 min and progressed until 57.5 ± 
23.67 min (mean ± SD, n = 6). Muscle paralysis occurred 
within 2 h of poisoning.
Skeletal muscle mitochondrial integrity and respiration 
in monocrotophos exposure
Mitochondrial swelling, respiration rates, respiratory control 
ratios (RCR) using substrates for complex I and II, and the 
activity of complex IV were not altered significantly in rats 
exposed to monocrotophos.
Enzyme activity of muscle mitochondrial complex V in 
rats exposed to monocrotophos
Complex V (ATP synthase) was significantly inhibited by 
55%  in  muscle  mitochondria  isolated  from  rats  treated 
with 0.8LD50 dose of monocrotophos compared to control 
animals (Fig. 1).242    S. Venkatesh et al.
Mitochondrial calcium uptake in rats exposed to 
monocrotophos
The  uptake  of  calcium  by  muscle  mitochondria  from 
monocrotophos  treated  animals  was  inhibited  60%  com-
pared to control animals (Fig. 2).
Nitric oxide levels in plasma and mitochondria of rats 
treated with monocrotophos
A significant increase in nitrate (measured as nitrite), the 
stable end product of NO, was noted in plasma and skel-
etal muscle mitochondria of paralyzed rats during the early 
phase  of  acute  monocrotophos  exposure  (0.8LD50  dose) 
(Fig. 3a and 3b, respectively).
Modification of reactive cysteines on ATP synthase 
subunits from rats treated acutely with monocrotophos
Protein levels of ATP synthase on 1D BN-PAGE (Fig. 4a) 
and  of  ATP  synthase  subunits  in  the  second  dimension 
SDS PAGE, from gels stained for total protein, did not differ 
between control and monocrotophos treated rats (Fig. 4b).
Blots probed for , , and OSCP subunits of ATP synthase 
resulted in detection of proteins at approximately 58, 52, 
and 27 kD (Fig. 4c).
Sulfhydryl labeling indicated that a number of ATP syn-
thase subunits were modified in acute monocrotophos expo-
sure. Six subunits with reactive cysteines were labeled under 
these conditions. The one at 57 kD showed approximately 
43% decrease in labeling, while the one at 18 kD showed a 50% 
reduction in labeling compared to controls (Fig. 4d and 4e). 
The fact that the molecular weights of these proteins corre-
lated closely with those obtained on the immunoblots for the 
, , and OSCP subunits suggested that these subunits were 
modified. In addition a 46 kD and 35 kD band also showed 
40% and 50% decrease in labeling, respectively. Sulfhydryl 
group modification appeared to be specific (to certain subu-
nits) and not a universal phenomenon in monocrotophos 
poisoning, since the two bands at 76 kD and 68 kD did not 
show any change in labeling after poisoning (Fig. 4d and 4e).
Inhibition of NOS and ATP synthase activity after 
monocrotophos exposure
L-NAME,  a  general  NOS  inhibitor,  treatment  of  animals 
increased plasma and muscle mitochondrial levels of nitrate 
compared to control animals, although the increase was not 
significant (Fig. 3a and 3b). L-NAME, however, prevented 
the increase in NO levels seen during monocrotophos expo-
sure  in  plasma  and  significantly  in  muscle  mitochondria 
(p < 0.05) (Fig. 3a and 3b, respectively).
Complex V activities (ATP synthase) did not differ signifi-
cantly between control, L-NAME, and L-NAME + monocro-
tophos treated animals (Fig. 1). This indicated that L-NAME 
inhibition  of  NOS  prevented  inhibition  of  ATP  synthase 
induced by monocrotophos exposure, which suggested that 
NO had a role to play in this process.
Figure 1.  Muscle mitochondrial complex V activity of control, monocro-
tophos (MCP), L-NAME, and L-NAME + MCP treated rats. Muscle mito-
chondria  were  isolated  from  control,  MCP,  L-NAME,  and  L-NAME  + 
MCP treated rats and complex V activity measured. Values are mean ± 
SD of nine control and six rats in all other groups. * p < 0.05 compared to 
Control. ** p < 0.05 compared to MCP.
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Figure 2.  Calcium uptake by muscle mitochondria isolated from   control 
and  monocrotophos  treated  rats.  Muscle  mitochondria  isolated  from 
control animals and after monocrotophos induced paralysis were used 
for measurement of calcium uptake using the dye Arsenazo III and fol-
lowing  absorbance  at  675/685  nm.  Values  are  mean  ±  SD  of  six  rats.   
*p < 0.05 compared to Control.
8 0 . 0
r
o
t
e
i
n
6 0 . 0
m
 
/
m
i
n
/
m
g
 
p
r
2 0 0
4 0 . 0
n
 
A
6
7
5
/
6
8
5
n
m
*
0
0. 2 0
C
h
a
n
g
e
 
i
n
0
P C M l o r t n o C
Figure  3.  Nitric  oxide  levels  in  plasma  and  muscle  mitochondria  of   
control, monocrotophos (MCP), L-NAME, and L-NAME + MCP treated 
rats. Nitrate, the stable end product of nitric oxide was measured (as 
nitrite) in plasma (a) and mitochondrial samples (b) from control, MCP 
treated, L-NAME, and L-NAME + MCP treated animals. Values are mean 
± SD of nine control and six rats in all other groups. *p < 0.05 compared to 
Control. **p < 0.05 compared to MCP.
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Prevention  of  NO  synthesis  by  L-NAME  significantly 
increased sulfhydryl labeling of ATP synthase subunits 57, 
46, 35, 18 kda by 4.5-, 1.3-, 4.7-, and 1.6-fold, respectively, 
compared to control animals (p < 0.05) (Fig. 4d). This signifi-
cant increase in sulfhydryl label of these ATP synthase subu-
nits was preserved in animals treated with L-NAME prior to 
monocrotophos treatment compared to those treated only 
with monocrotophos (p < 0.05) (Fig. 4). This data further 
supports the role of NO in the modification of sulfhydryl 
groups on ATP synthase in monocrotophos exposure.
Discussion
OPP results in rapid toxicity due to efficient absorption and high 
affinity of binding to AChE of these compounds. The nature 
and rapidity of the toxicity may explain why cellular events that 
occur in the early phase of poisoning initiate prolonged muscle 
pathology. Muscle weakness of OPP patients is associated with 
muscle damage that occurs early in the poisoning (John et al. 
2003). This study was to elucidate intracellular mechanisms in 
muscle that occur soon after acute OPP that may contribute to 
muscle injury and focused on the mitochondria.
It was found that acute exposure to monocrotophos did 
not  affect  skeletal  muscle  mitochondrial  respiration  or 
coupling to oxidative phosphorylation which need to be 
tightly coupled in order to generate ATP for cellular energy. 
The activity of ATP synthase was, however, decreased by 
55%. This would result in levels of ATP which may be insuf-
ficient to maintain the integrity of the cell (Wilkinson and 
Robinson 1974) and therefore contribute to muscle weak-
ness and injury that occurs in acute OPP.
Mitochondria  also  contribute  to  maintaining  calcium 
homeostasis in the muscle by calcium uptake through a 
uniporter, a process that requires ATP (Moreau et al. 2006). 
The  inhibition  of  energy-dependent  mitochondrial  Ca2+ 
influx observed in this study may lead to elevated sarco-
plasmic Ca2+ that can injure the muscle. Muscle damage 
induced within 2 h of exposure to organophosphates has 
been shown earlier by Leonard and Salpeter (1979) to be a 
myopathy mediated by calcium.
Interventions that prevent or reduce ATP synthase inhi-
bition in OPP may decrease the resulting muscle injury. 
Increased NO levels are known to disrupt muscle contrac-
tion, cause muscle weakness and fatigue, and to underlie 
muscle  degeneration  and  toxicity  of  organophosphate 
poisoned rats (Jeyarasasingam et al. 2000; Gupta et al. 2002; 
Smith and Reid 2006). The data in this study also showed 
increased systemic levels of NO in acute monocrotophos 
Figure 4.  Sulfhydryl group reactivity of muscle mitochondrial ATP synthase from control, monocrotophos (MCP), L-NAME, and L-NAME + MCP treated 
rats. Muscle mitochondria isolated from control and monocrotophos poisoned rats were subjected to 2D BN-PAGE, immunoblotting and sulfhydryl 
labeling. (a) First dimension blue native gel after staining with coomassie blue (Complex V (CV) indicated with arrow) and immune blot after probing 
with the a-subunit of ATP synthase. (b) Second dimension SDS-PAGE gel of ATP synthase identified and excised from the 1st dimension gel, stained 
with coomassie blue. (c) Immune blot of the 2nd dimension SDS-PAGE gel with separated ATP synthase subunits after probing with the anti--subunit, 
anti-b-subunit, and anti-OSCP subunit of ATP synthase. (d) Sulfhydryl group labeling on the 2nd dimension SDS-PAGE gel with separated ATP synthase 
subunits using biotin maleimide in controls and monocrotophos poisoned animals in the presence and absence of L-NAME, an NOS inhibitor. (a–d) 
are representative of one control and one monocrotophos treated rat. (e) The intensity of sulfhydryl labeled bands in (d) were determined and plotted as 
fold change from control. Values are mean ± SD of three rats. *p < 0.05 compared to Control. #p < 0.05 compared to MCP treated rats.
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exposure that correlated to the inhibition of ATP synthase, 
as inhibition of NOS and reduction of NO levels resulted in 
partial recovery of ATP synthase activity. These results sup-
port the studies of Gupta et al. (2002) that show a marked 
decrease in rat muscle and brain ATP levels, within an hour 
of treatment with the organophosphate compound diisopro-
pylphosphorofluoridate.  This  decrease  was  accompanied 
by an increase in NO levels. Nitric oxide is also implicated 
in toxicity to the brain in organophosphate pesticide and 
nerve agent poisoned rats (Chang et al. 2001; Damodaran 
et al. 2006). In the brain, organophosphates disrupt respi-
ration by inhibition of Complex I/IV (Yen et al. 2004). This 
clearly differs from the situation in organophosphate poi-
soned paralyzed muscle where NO targets Complex V (ATP 
synthase).
NO is known to modify reactive cysteines on proteins 
through post-translational modification and initiate sign-
aling (Jaffrey et al. 2001). To explore the possibility of such 
modifications on mitochondrial ATP synthase, we used a 
proteomics approach coupled to labeling reactive cysteines 
with biotinylated maleimide. The labeling of four subunits 
of ATP synthase was substantially decreased in monocro-
tophos exposure. This suggested that certain subunits of 
ATP synthase are susceptible to thiol modification subse-
quent to acute monocrotophos exposure. NO may play a 
role in this modification as it was prevented by L-NAME 
treatment.
L-NAME treatment was expected to reduce NO levels to 
less than those in controls. Paradoxically, plasma and mito-
chondrial NO levels were higher, although not significantly, 
in  the  L-NAME  treated  animals  compared  to  controls. 
Chronic low dose L-NAME treatment of rats is known to 
activate NO synthesis through negative feedback regulation 
of NOS by NO and may also account for the observations 
in this study (Bernatova et al. 2007). The lower NO levels 
in L-NAME + monocrotophos treated animals compared to 
those treated only with L-NAME lend support to negative 
feedback regulation of NOS by NO in animals on the treat-
ment schedule of this study.
L-NAME  inhibition  of  NO  synthesis  is  associated  with 
increased  levels  of  glutathione  (GSH)  in  animals  (Schild 
et al. 2003). Under these conditions NO induced by negative 
feedback inhibition of NOS may be rapidly oxidized by GSH 
to GSNO, the transport and storage form of NO. This seques-
tration  of  NO  may  explain  the  increased  free  sulfyhdryl 
groups on ATP synthase subunits observed in L-NAME and 
L-NAME + monocrotophos treated rats compared to control 
animals during the initial phase of poisoning.
In conclusion, the studies demonstrate that muscle mito-
chondrial  ATP  synthase  is  inhibited  in  paralyzed  muscle 
during the early phase of acute monocrotophos exposure, 
an  effect  possibly  mediated  through  NO.  The  inhibition 
of ATP synthase may be responsible for reduced calcium 
uptake by the mitochondria, which can affect cellular cal-
cium homeostasis and lead to muscle damage. As inhibition 
of NOS appears to protect against modification and inhibi-
tion of ATP synthase, scavenging NO early in OPP may help 
maintain myocyte integrity and prevent muscle weakness. 
This is currently under study.
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